The rates are remarkably similar across all three, despite their different mechanisms: Semaglutide: Nausea approximately 18%, diarrhea approximately 12%, vomiting approximately 8% Tirzepatide: Nausea 17-22% (dose dependent), diarrhea 13-16%, vomiting 6-10% Retatrutide: Nausea 16-25% (dose dependent), diarrhea 15-22%, vomiting 8-13% The pattern holds consistently
Other ingredients: beetroot powder, anticaking agent (silicon dioxide), orange flavor, acidity regulator (citric acid monohydrate), noniodized sea salt, sweetener (sucralose), colorant (Sunset Yellow FCF / orangeyellow) Warnings Food supplements do not replace a varied and balanced diet or a healthy lifestyle
This is when they release pro-inflammatory signals that can actually hinder long-term healing
A typical acute injury protocol begins with 0.25 mg twice daily for the first week, reduces to 0.5 mg once daily for weeks two through four, then continues at 0.25 mg daily for weeks five and six if needed
KLOW and GLOW are typically discussed for different research purposes
